Yujin Hoshida

Yujin Hoshida, M.D., Ph.D., is a Professor in the Department of Internal Medicine at the University of Texas Southwestern Medical Center and Director of the Liver Tumor Translational Research Program. His expertise spans molecular classification, prognostic prediction, and targeted therapies for liver cirrhosis and cancer. He leads international genomics projects, including the Precision Liver Cancer Prevention Consortium, focusing on biomarker discovery, chemoprevention, and systems biology approaches.

Education: M.D. from University of Tsukuba; Ph.D. in Medical Sciences from University of Tokyo. Postdoctoral training at University of Tokyo and Broad Institute of MIT/Harvard. Professional affiliations include American Association for Cancer Research and American Gastroenterological Association.

Research interests include liver cancer risk stratification, personalized screening, and informatics methodologies using liquid biopsy, single-cell omics, and computational tools. His lab develops blood-based biomarkers for cirrhosis progression and HCC risk, integrating clinical, spatial, and cross-species data.

Notable contributions: Development of the PLSEC-AFP risk prediction model; leader in translational liver cancer research with a focus on geographic and demographic-specific biomarkers. Ongoing initiatives include AI-driven histopathology analysis and drug development for precision medicine.